Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia.

about

Dynamic response of C-type natriuretic peptide and its aminoterminal propeptide (NTproCNP) to growth hormone treatment in children with short stature.

P2860

Q53099876-E6DA98D8-274A-48C1-B12B-27020E6DC97A

P2860

Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia.

Item

http://www.wikidata.org/entity/Q53194226

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Serum NT-proCNP levels increas ...... ondroplasia/hypochondroplasia.

@en

Serum NT-proCNP levels increas ...... ondroplasia/hypochondroplasia.

@nl

type

Item

label

Serum NT-proCNP levels increas ...... ondroplasia/hypochondroplasia.

@en

Serum NT-proCNP levels increas ...... ondroplasia/hypochondroplasia.

@nl

prefLabel

Serum NT-proCNP levels increas ...... ondroplasia/hypochondroplasia.

@en

Serum NT-proCNP levels increas ...... ondroplasia/hypochondroplasia.

@nl

P1476

Serum NT-proCNP levels increas ...... hondroplasia/hypochondroplasia

@en

P2093

Hirofumi Nakayama

http://www.w3.org/2001/XMLSchema#string

Keiichi Ozono

http://www.w3.org/2001/XMLSchema#string

Keiko Yamamoto

http://www.w3.org/2001/XMLSchema#string

Kohji Miura

http://www.w3.org/2001/XMLSchema#string

Makiko Tachibana

http://www.w3.org/2001/XMLSchema#string

Makoto Fujiwara

http://www.w3.org/2001/XMLSchema#string

Noriyuki Namba

http://www.w3.org/2001/XMLSchema#string

Satoshi Takakuwa

http://www.w3.org/2001/XMLSchema#string

Taichi Kitaoka

http://www.w3.org/2001/XMLSchema#string

Takuo Kubota

http://www.w3.org/2001/XMLSchema#string

P2860

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature

Identification and functional characterization of two novel NPR2 mutations in Japanese patients with short stature

Furin-mediated processing of Pro-C-type natriuretic peptide

Dwarfism and early death in mice lacking C-type natriuretic peptide

Growth hormone therapy in achondroplasia.

Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.

A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B.

Amino-terminal propeptide of C-type natriuretic peptide (NTproCNP) predicts height velocity in healthy children.

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.

P304

845-850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEN.13025

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yasuhisa Ohata

P577

2016-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26814021

http://www.w3.org/2001/XMLSchema#string

Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia.

about

P2860

P2860

Serum NT-proCNP levels increased after initiation of GH treatment in patients with achondroplasia/hypochondroplasia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698